CONFERENCE AGENDA

EVENT SCHEDULE

It’s an Amazing event for All over the World Clinical Diagnostics Community


Time
Session
Speakers
08:30
Registration & Refreshments
09:15
Chair Person Remarks
Dr Andrew Sails
Head of Molecular Diagnostics and Research and Development, Public Health England
09:30
Opening Keynote 1
Super Selective Primers for Multiplex Real-time PCR Assays that Assess the Abundance of Rare Mutations Associated with Cancer

Dr Fred Kramer
Public Health Research Institute,
Rutgers University
10:30
Opening Keynote 2
3 Decades of technological revolutions could not stop antibiotics misuse - Why? The challenge of actionable Dx.

  • • Discuss the problem of Abx misuse
  • • Discuss the technologies that were introduced to the market and their limited impact
  • • Discuss alternative approaches and their potential impact

  • Dr Kfir Oved
    CTO, MeMed Diagnostics,
    Israel
    11:15
    Morning Refreshment Break, Poster Viewing and Exhibition
    11:30
    Multiplex Microbead Quantitative PCR and Digital PCR technologies
    Dr. Stefan Rödiger
    Group Leader, Institute of Biotechnology,
    BTU Cottbus - Senftenberg
    Antimicrobial resistance and Point of Care Testing

    12:00
    Rapid, User-Friendly, Sample-to-Result Diagnostic Sequencing
    • Where I’ve come from and the remarkable story of NGS
    • How I see diagnostic NGS
    • Overview ofour efforts at DNA Electronics including development of a semiconductor DNA Sequencing Platform
    • Applications in infectious diseases and beyond
    Nick McCooke
    Pioneer in NGS Technology & Founder CEO of SOLEXA (now ILLUMINA)
    Chief Business Officer
    DNA Electronics, UK
    12:30
    Networking Luncheon by Hilton's Master Chef
    13:45
    Biomarkers for Translational Research
    Dr Karen Kempsell
    Senior Project Team Leader,
    Public Health England TBC
    14:15
    How engaging with a product development consultancy can benefit your diagnostics device development programme?
    Carmelo Volpe
    Head of Diagnostics
    Cambridge Consultants, UK
    14:45
    Bedside NGS diagnostics for the Oligonucleotide Therapeutics Market:
    From Patient selection to Drug Efficacy Quantification
    Dr.Sterghios A.
    Moschos Associate Professor,
    Department of Applied Sciences,
    Northumbria University
    15:15
    The Intersection of qPCR, digital PCR and Next Generation Sequencing: Improved Detection and Quantitation of Infectious Agents
    • Quantitation of viruses is increasingly important in clinical care
    • Interlaboratory comparison of quantitative data is challenging
    • dPCR and NGS reveal the causes of poor Interlaboratory agreement and suggest a pathway forward
    Keith R. Jerome
    Member
    Vaccine and Infectious Disease Division
    Fred Hutchinson Cancer Research Center
    Professor and Head, Virology Division
    Department of Laboratory Medicine
    University of Washington
    16:00
    Rapid Diagnostics to reduce Antimicrobial Resistance
    • Better diagnostics is needed to guide antimicrobial therapy, patient management and drug development
    • Point of care testing has great potential across healthcare settings and use cases
    • Electrochemical biosensors enable cost effective and rapid diagnostics at point of care
    Dr Till Bachman
    Deputy Head of Division of Infection and Pathway Medicine,
    University of Edinburgh
    16:30
    Afternoon Refreshment Break, Poster Viewing & Exhibition
    16:45
    Collaborating to deliver international trials
    Bridging the gap between the health service, academia and the life sciences industry
    Divya Chandha Menak
    Head of Business Development
    National Institute for Health Research
    17:15
    Chair Person Closing Remarks
    17:20
    Global Networking and Drinks Reception
    18:30
    End of Conference